Back to News
Market Impact: 0.3
PROCEPT BioRobotics Q3 Earnings Call Highlights
Source: marketbeat.com
Corporate EarningsHealthcare & BiotechCompany Fundamentals
PROCEPT BioRobotics reported 18% revenue growth in Q3 2026, supported by demand for HYDROS systems and procedure-related products. Growth was partly offset by slower-than-expected placements at new U.S. accounts.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
PRCT0.30
More News
- Tech stocks are suffering their biggest selloff since Covid, as investors see premature end to AI datacenter boom
- Elon Musk's Tesla and SpaceX lose over $420 billion in combined market cap after midterms
- We're raising our price target on Cardinal Health after another stellar quarter of profits
- Costco is taking aim at its May record high — how it got here and where's it going
- Neocloud IREN says $4 billion in annualized revenue being delayed due to customer request
- Tapestry CEO on Earnings Beat, Consumer Outlook